Follow the company. Check the evidence.
Public records connected to stocks traded by Congress. See what changed, when it became public, and the original source.
DHR: Financial results
Filed 8-K for an event or period dated 2026-10-21. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-25. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: third_quarter 2026 lobbying report
Issues related to biotechnology, cell and gene therapy General issues related to tariffs
Public: Oct 20, 2026, 3:43 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: third_quarter 2026 lobbying report
Issues Related to biotech and bio manufacturing.
Public: Oct 20, 2026, 1:18 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: third_quarter 2026 lobbying report
Issues related to a manufacturing rebate program for domestic production of life sciences products.
Public: Oct 20, 2026, 11:14 AM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: third_quarter 2026 lobbying report
A lobbying activity report was filed. Income and expenses are separate reporting measures and must not be added together.
Public: Oct 16, 2026, 5:38 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: third_quarter 2026 lobbying report
Issues pertaining to the regulation of cell and gene therapy products. Issues pertaining to the biomedical research enterprise. H.R. 8646, FY 2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, Issues related to cell and gene therapy products at FDA.
Public: Oct 14, 2026, 4:29 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: Leadership change · Other company developments
Filed 8-K for an event or period dated 2026-10-09. Leadership change; Other company developments.
1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: Leadership change · Company disclosure · Other company developments
Filed 8-K for an event or period dated 2026-07-31. Leadership change; Company disclosure; Other company developments.
1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: Financial results
Filed 8-K for an event or period dated 2026-07-21. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-06-26. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: second_quarter 2026 lobbying report
Issues related to biotechnology, cell and gene therapy General issues related to tariffs Issues related to decarbonization
Public: Jul 20, 2026, 1:11 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: second_quarter 2026 lobbying report
Issues related to a manufacturing rebate program for domestic production of life sciences products.
Public: Jul 20, 2026, 10:02 AM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: second_quarter 2026 lobbying report
Issues pertaining to the regulation of cell and gene therapy products. Issues pertaining to the biomedical research enterprise.
Public: Jul 16, 2026, 6:17 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: second_quarter 2026 lobbying report
Issues Related to biotech and bio manufacturing.
Public: Jul 16, 2026, 12:19 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: second_quarter 2026 lobbying report
A lobbying activity report was filed. Income and expenses are separate reporting measures and must not be added together.
Public: Jul 6, 2026, 2:37 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: New financial obligation · Other company developments
Filed 8-K for an event or period dated 2026-06-03. New financial obligation; Other company developments.
1 congressional household disclosed purchases in the past 90 days. See the trades
DHR: second_quarter 2026 lobbying report
Issues pertaining to the regulation of cell and gene therapy products; Issues pertaining to the biomedical research enterprise Issues pertaining to the regulation of cell and gene therapy products; Issues pertaining to the biomedical research enterprise
Public: May 18, 2026, 1:27 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
Connections describe public records, not evidence of wrongdoing or a prediction of returns. Event dates can precede publication by days or months. When a source has no public-release timestamp, we show when we first observed it.
Source coverage
Coverage is growing across companies already tracked here. A scan can return no matching records. This feed is not a complete record of every filing or agency action.
- SEC EDGAR
- Current across tracked companies505 of 505 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:26 PM EST
- USAspending
- Collection in progress96 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:27 PM EST
- SAM.gov
- Awaiting company connections
- Lobbying disclosures
- Not yet scanned0 of 548 companies scanned in the past 12 hours
- Congress.gov
- Current across tracked companies5 of 5 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:27 PM EST
- Federal Register
- Collection in progress288 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:27 PM EST
- Regulations.gov
- Collection in progress29 of 53 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:28 PM EST
- FEC campaign finance
- Stale — refresh overdue0 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 11, 2026, 1:28 PM EST